🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🚨 Here's a video showing how to create a encircling line drawing to highlight text or object. Very useful to guide the eye of the viewer to an item being discussed. Thanks for retweeting! youtu.be/CP9NVlrtaZc

New paper from our team on the dynamics of nocturnal arrhythmia avalanches during sleep 🛌💤 Sobhan Salari Shahrbabaki onlinelibrary.wiley.com/doi/10.1111/js…

"AHRS Webinar of Lead Extraction 2025 - Basic Course" will be held on 27 February 2025, Thursday from 6pm - 7.30pm SGT. Register now at tinyurl.com/bdcp8emd

Significantly less acute brain emboli among left ventricular catheter ablation patients randomized to a transseptal versus a retrograde aortic approach per our The Patient-Centered Outcomes Research Institute-funded #TRAVERSE trial. Thank you to our patients who helped design and implement the study, my generous EP

This is Marco Rubio explaining how the USA promised to defend Ukraine forever if they got rid of their nuclear arsenal left after the Soviet Union fell. This is why lil marco was sinking into the couch. He was hoping we wouldn’t find it…so don’t RT right now this very second.

.Gareth Wynn -- Lead extraction vs. Abandonment Concern about tricuspid valve is a newly recognized issue. #TALES2025 #EPeeps

.Gareth Wynn -- Lead extraction vs abandonment: #TALES2025 #EPeeps

Even with this CHAMPION trial - a focus on binary recurrence misses the observation that the AF burden (time spent in AF) was exceedingly low following intervention, and QOL was effectively normalised. Meaning patients had significant benefit from the treatment.

Nice to see it "proven" but did anyone really think asymptomatic AF was different n terms of these outcomes? Difficulties when discussing with patients is the lack of good trial evidence to show that we can make a difference

Or, not rare...who knows?

The latest video in our partnership with Dr. Glaucomflecken summarizes the results of the VANISH2 trial, which compared catheter ablation versus antiarrhythmic drug therapy for ventricular tachycardia. View the full article for free: nej.md/DrG16

The AMA Victoria team has been out at the Austin Health clinical school today with our friends from Doctors for the Environment Australia to support an important interdisciplinary workshop on sustainable healthcare, attended by final year students from University of Melbourne.

Two amazing days at this year’s CIED implanter’s Masterclass ANZ Cardiac Rhythm Masterclass